New expertise profiles are welcomed to the Board of Biomendex. 

Olli Gestranius shall continue serving as the chairman of the Board for a second term, and Antero Salo will continue his term. The Board is completed with new members: Anna-Maria Henell, Kaisla Lahdensuo, Kalevi Heinonen and Robert Ashorn.

We are delighted to welcome you all!

With this focused subject matter expertise, the new Board continue supporting the CEO Pasi Kankaanpää and core team in strengthening our veterinary business expansion into new geographical markets, as well as initiating new registration activities and adjusting the strategy for future clinical (human) orthopedic product launches.

Finally, we would like to express our gratitude to our shareholders for your trust, and sincerely thank Veli-Matti Lahti, Teemu Sipilä, Mikko Latvala, and Ralph Ashorn for their contributions within the previous Board term/s.

Topics: Business, News